Fidelity Investments
TYRA icon

Fidelity Investments’s Tyra Biosciences TYRA Stock Holding History

Fidelity Investments’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$230M Buy
10,538,463
+1,617,950
+18% +$44.5M 0.01% 878
2026
Q2 		$285M Buy
8,920,513
+1,172,865
+15% +$38.8M 0.01% 782
2026
Q1 		$297M Buy
7,747,648
+7,735,085
+61,570% +$250M 0.02% 694
2025
Q4 		$330K Buy
12,563
+34
+0.3% +$624 ﹤0.01% 3234
2025
Q3 		$175K Buy
12,529
+327
+3% +$3.73K ﹤0.01% 3407
2025
Q2 		$117K Sell
12,202
-1,694,946
-99% -$16.1M ﹤0.01% 3549
2025
Q1 		$15.9M Sell
1,707,148
-1,400,822
-45% -$18.1M ﹤0.01% 1754
2024
Q4 		$43.2M Sell
3,107,970
-264,880
-8% -$4.81M ﹤0.01% 1438
2024
Q3 		$79.3M Buy
3,372,850
+26,187
+0.8% +$550K ﹤0.01% 1193
2024
Q2 		$53.5M Sell
3,346,663
-630,545
-16% -$10.9M ﹤0.01% 1292
2024
Q1 		$65.2M Buy
3,977,208
+1,208,512
+44% +$19.8M ﹤0.01% 1217
2023
Q4 		$38.3M Sell
2,768,696
-1,130,131
-29% -$14.6M ﹤0.01% 1392
2023
Q3 		$53.7M Sell
3,898,827
-218,042
-5% -$3.23M ﹤0.01% 1216
2023
Q2 		$70.1M Buy
4,116,869
+968,882
+31% +$14.1M 0.01% 1141
2023
Q1 		$50.6M Sell
3,147,987
-731,136
-19% -$8.7M ﹤0.01% 1260
2022
Q4 		$29.5M Sell
3,879,123
-147,178
-4% -$1.04M ﹤0.01% 1467
2022
Q3 		$35.4M Buy
4,026,301
+58,211
+1% +$532K ﹤0.01% 1382
2022
Q2 		$28.4M Sell
3,968,090
-121,995
-3% -$971K ﹤0.01% 1508
2022
Q1 		$43.8M Buy
4,090,085
+621,254
+18% +$7.37M ﹤0.01% 1451
2021
Q4 		$48.8M Buy
3,468,831
+1,560,172
+82% +$31M ﹤0.01% 1429
2021
Q3 		$33.6M Buy
+1,908,659
New +$36.5M ﹤0.01% 1599

Other funds holding TYRA

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Canaan Partners XI
Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Fidelity Investments's TYRA Position: Q3 2026 in Review

Fidelity Investments increased its Tyra Biosciences (TYRA) stake by 18% in Q3 2026, buying an estimated $44.5M and bringing the position to 10,538,463 shares worth $230M. The position accounts for 0.01% of the portfolio, ranked #878.

Fidelity Investments first reported a position in TYRA in Q3 2021 and has held it in 21 quarters since. The position peaked at $297M in Q1 2026. 65 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Fidelity Investments held 10,538,463 shares of Tyra Biosciences worth $230M as of Q3 2026.
  • Fidelity Investments bought 1,617,950 Tyra Biosciences shares in Q3 2026, an estimated $44.5M.
  • Tyra Biosciences made up 0.01% of Fidelity Investments's portfolio in Q3 2026, its #878 holding.
  • Fidelity Investments first reported a position in Tyra Biosciences in Q3 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Tyra Biosciences position peaked at $297M in Q1 2026.
  • 65 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.